Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial
Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page
- ChecktodayChange DetectedFooter shows Revision: v3.6.5, replacing Revision: v3.6.4, indicating a minor site version update. This reflects an under-the-hood update to the interface rather than a change to study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page version label has been updated from v3.6.3 to v3.6.4. This reflects a minor update to the page’s rendering or underlying template.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now shows a new revision stamp (v3.6.3) replacing the previous v3.6.2, indicating a minor deployment update.SummaryDifference0.1%

- Check44 days agoChange DetectedFooter revision label updated from v3.6.0 to v3.6.2, signaling a new build of the page. The change does not affect the displayed study details or navigation.SummaryDifference0.1%

- Check58 days agoChange DetectedThe listing now displays 'No longer looking for participants', signaling that enrollment has ended; additional help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to guide users.SummaryDifference0.5%

- Check65 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, representing a small maintenance update without visible content changes.SummaryDifference0.1%

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.